Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...

Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

New science shows age reversal may be within reach by targeting cellular aging mechanisms and restoring youthful biological ...

Learn more about platelets, small types of blood cells that prevent excessive bleeding and serve other important purposes.

When fruit flies are infected with the Wolbachia bacteria, their sex lives—and ability to reproduce—change dramatically.

A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in people with type 2 diabetes (T2D).

Mice whose MTCH2 proteins were silenced, or deleted, developed increased athletic capacity – they grew more muscle fibers, ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

A key enzyme and its molecular pathway are critical to keeping certain immune cells active and away from "exhaustion," ...

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...